Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 15-Mar 2023. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 113320811000001117 | Olmesartan + Hydrochlorothiazide (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 113320821000001114 | Olmesartan + Hydrochlorothiazide | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Olmesartan + Hydrochlorothiazide | Is a | Product containing hydrochlorothiazide and olmesartan (medicinal product) | false | Inferred relationship | Existential restriction modifier | ||
| Olmesartan + Hydrochlorothiazide | Is a | Virtual therapeutic moiety | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet | Is a | False | Olmesartan + Hydrochlorothiazide | Inferred relationship | Existential restriction modifier | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | Is a | False | Olmesartan + Hydrochlorothiazide | Inferred relationship | Existential restriction modifier | |
| Olmesartan medoxomil 20mg / Hydrochlorothiazide 25mg tablets | Is a | False | Olmesartan + Hydrochlorothiazide | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR